Search research articles
Contact Us
Filters
Showing results (31-40 of 92) with videos related to
Page
of 10
Sort By:
Experimental and Molecular Pathology
|
April 7, 2022
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
David Dum, Anne Menz, Cosima Völkel, et al.
Biomed Research International
|
November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence
Simon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors
Viktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Molecular and Cellular Endocrinology
|
November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors
Katharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
World Journal of Urology
|
November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer
Simon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Biomedicines
|
October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors
Sören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Virchows Archiv : an International Journal of Pathology
|
September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
Cosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Molecular Medicine (Cambridge, Mass.)
|
March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
Christoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis
|
September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer
Simon Kind, Annika Jaretzke, Franziska Büscheck, et al.
Archives of Pathology & Laboratory Medicine
|
August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors
David Dum, Daniela Kromm, Maximilian Lennartz, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 92) with videos related to
Sort By:
Page
of 10
Experimental and Molecular Pathology
|
April 7, 2022
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
David Dum, Anne Menz, Cosima Völkel, et al.
Biomed Research International
|
November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence
Simon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
January 17, 2023
GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors
Viktor Reiswich, Carol E Schmidt, Maximilian Lennartz, et al.
Molecular and Cellular Endocrinology
|
November 11, 2023
Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors
Katharina Möller, Ria Uhlig, Natalia Gorbokon, et al.
World Journal of Urology
|
November 21, 2019
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer
Simon Kind, Franziska Büscheck, Doris Höflmayer, et al.
Biomedicines
|
October 27, 2022
Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors
Sören Weidemann, Nessar Ahmad Noori, Maximilian Lennartz, et al.
Virchows Archiv : an International Journal of Pathology
|
September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
Cosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Molecular Medicine (Cambridge, Mass.)
|
March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
Christoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis
|
September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer
Simon Kind, Annika Jaretzke, Franziska Büscheck, et al.
Archives of Pathology & Laboratory Medicine
|
August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors
David Dum, Daniela Kromm, Maximilian Lennartz, et al.
Page
of 10